MIRUM PHARMACEUTICALS AND INCYTE ANNOUNCE U.S. FDA APPROVAL OF ATEBRIOZ™ (ZILURGISERTIB) FOR ADULT AND PEDIATRIC PATIENTS WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

Reuters · 2d ago

Please log in to view news